Old Web
English
Sign In
Acemap
>
authorDetail
>
Kate Reed
Kate Reed
Alfred Hospital
Medicine
Immunology
Cohort
Internal medicine
Multiple myeloma
4
Papers
18
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Identification of Acetylation, Immune Cell Alterations and Gene Signature As Dynamic Biomarkers of Response to Panobinostat Treatment in Multiple Myeloma Patients
2017
Blood
Sridurga Mithraprabhu
Ioanna Savvidou
Malarmathy Ramachandran
Anna Kalff
Tiffany Khong
Kate Reed
John V. Reynolds
Andrew Spencer
Show All
Source
Cite
Save
Citations (0)
Determination of the Maximum Tolerated Dose of Panobinostat in Combination with a 5-Day Schedule of Azacitidine in High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia: Planned Interim Analysis of a Phase Ib/II Study
2011
Blood
Peter Tan
Kate Reed
Patricia A. Walker
Sharon Avery
Sushrut Patil
Andrew Grigg
Peter Mollee
Othon L. Gervasio
Ivo J. Winiger
Dirk Hönemann
Andrew Wei
Andrew Spencer
Show All
Source
Cite
Save
Citations (4)
A multicenter phase 2 study of risk-adjusted salvage chemotherapy incorporating vinorelbine and gemcitabine for relapsed and refractory lymphoma†
2008
Cancer
Sant-Rayn Pasricha
Andrew Grigg
John Catalano
Michael Leahy
Craig Underhill
Christopher Arthur
James D'Rozario
Rm Lowenthal
Kate Reed
Andrew Spencer
Show All
Source
Cite
Save
Citations (14)
Fluvastatin-Zometa (FluZom) as A Possible Therapeutic Approach to Plasma Cell Disorders.
2004
Blood
Andrew Spencer
Cindy Baulch-Brown
Kate Reed
Kevin Lynch
Show All
Source
Cite
Save
Citations (0)
1